Zura Bio Limited Stock Alpha and Beta Analysis

ZURA Stock   2.73  0.20  6.83%   
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Zura Bio Limited. It also helps investors analyze the systematic and unsystematic risks associated with investing in Zura Bio over a specified time horizon. Remember, high Zura Bio's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Zura Bio's market risk premium analysis include:
Beta
1.87
Alpha
(0.50)
Risk
4.83
Sharpe Ratio
(0.12)
Expected Return
(0.57)
Please note that although Zura Bio alpha is a measure of relative return and represented here as a single number, it indicates the percentage above or below your selected benchmark (i.e., Dow Jones Industrial index.) So in this particular case, Zura Bio did 0.50  worse than the index. Remember, a high alpha is always good. Beta, on the other hand, measures the volatility (or risk) of an investment. It is an indication of Zura Bio Limited stock's relative risk over its benchmark. Zura Bio Limited has a beta of 1.87  . As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Zura Bio will likely underperform. At present, Zura Bio's Book Value Per Share is projected to increase slightly based on the last few years of reporting. The current year's Tangible Book Value Per Share is expected to grow to 2.67, whereas Enterprise Value Over EBITDA is projected to grow to (0.69).
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
  
Check out Zura Bio Backtesting, Zura Bio Valuation, Zura Bio Correlation, Zura Bio Hype Analysis, Zura Bio Volatility, Zura Bio History and analyze Zura Bio Performance.

Zura Bio Market Premiums

Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Zura Bio market risk premium is the additional return an investor will receive from holding Zura Bio long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Zura Bio. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Zura Bio's performance over market.
α-0.5   β1.87

Zura Bio expected buy-and-hold returns

Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Zura Bio's Buy-and-hold return. Our buy-and-hold chart shows how Zura Bio performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.

Zura Bio Market Price Analysis

Market price analysis indicators help investors to evaluate how Zura Bio stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Zura Bio shares will generate the highest return on investment. By understating and applying Zura Bio stock market price indicators, traders can identify Zura Bio position entry and exit signals to maximize returns.

Zura Bio Return and Market Media

The median price of Zura Bio for the period between Tue, Aug 27, 2024 and Mon, Nov 25, 2024 is 4.13 with a coefficient of variation of 12.41. The daily time series for the period is distributed with a sample standard deviation of 0.5, arithmetic mean of 4.06, and mean deviation of 0.39. The Stock received substential amount of media coverage during this period.
 Price Growth (%)  
       Timeline  
1
Disposition of 51728 shares by Sidhu Someit of Zura Bio at 3.87 subject to Rule 16b-3
09/04/2024
2
Zura Bio Receives New Coverage from Analysts at HC Wainwright - MarketBeat
09/05/2024
3
Disposition of 3800000 shares by Thiara Parvinder of Zura Bio at 2.7 subject to Rule 16b-3
09/11/2024
4
Piper Sandler maintains Overweight rating on Zura Bio shares - Investing.com
09/19/2024
5
Acquisition by Nistala Kiran of 350000 shares of Zura Bio at 3.98 subject to Rule 16b-3
09/20/2024
6
Zura Bio Limited Sees Large Increase in Short Interest - MarketBeat
09/27/2024
7
Zura Bio Stock Rating Reaffirmed by Cantor Fitzgerald
10/18/2024
8
JATT Acquisition Trading Down 2.7 percent Heres What Happened
10/31/2024
9
Piper Sandler sets price target on Zura Bio shares, cites positive trial data - Investing.com
11/05/2024
10
Guggenheim maintains Buy on Zura Bio, target steady at 15
11/08/2024
11
ADAR1 Capital Management, LLC Acquires New Stake in Zura Bio Ltd
11/15/2024
12
Were Hopeful That Zura Bio Will Use Its Cash Wisely
11/22/2024

About Zura Bio Beta and Alpha

For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Zura or other stocks. Alpha measures the amount that position in Zura Bio Limited has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.

Zura Bio Upcoming Company Events

As portrayed in its financial statements, the presentation of Zura Bio's financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Zura Bio's leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Zura Bio's public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Zura Bio. Please utilize our Beneish M Score to check the likelihood of Zura Bio's management manipulating its earnings.
26th of March 2024
Upcoming Quarterly Report
View
10th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
26th of March 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

Build Portfolio with Zura Bio

Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.

Build Diversified Portfolios

Align your risk with return expectations

By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
When determining whether Zura Bio Limited offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Zura Bio's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Zura Bio Limited Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Zura Bio Limited Stock:
Check out Zura Bio Backtesting, Zura Bio Valuation, Zura Bio Correlation, Zura Bio Hype Analysis, Zura Bio Volatility, Zura Bio History and analyze Zura Bio Performance.
You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
Zura Bio technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Zura Bio technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Zura Bio trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...